PIMCO RAFI Dynamic Multi-Factor International Equity ETF
MFDX - ETF AI Analysis
Top Page
PIMCO RAFI Dynamic Multi-Factor International Equity ETF (MFDX)
MFDX, the PIMCO RAFI Dynamic Multi-Factor International Equity ETF, earns a solid overall rating thanks to its exposure to high-quality global leaders like Novartis, ASML, and Zurich Insurance, which show strong financial performance, healthy balance sheets, and supportive long-term business trends. The fund’s score is held back somewhat by more mixed names such as Glencore and BP, where profitability, leverage, and valuation concerns introduce additional risk. A key risk factor is the ETF’s reliance on large international companies in sectors like pharmaceuticals, financials, energy, and industrials, which can be sensitive to global economic cycles and regulatory changes.
MFDX vs. SPDR S&P 500 ETF (SPY)
- AUM
- 411.47M
- Region
- Developed Markets
- Expense Ratio
- 0.39%
- Beta
- 0.64
- Issuer
- PIMCO
- Inception Date
- Aug 31, 2017
- Dividend Yield
- 3.09%
- Asset Class
- Equity
- Index Tracked
- RAFI Dynamic Multi-Factor Developed Ex-U.S. Index
MFDX Summary
MFDX is an international stock ETF that follows the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index. It invests in companies from countries like Japan, the UK, and Europe, across many sectors such as financials, industrials, and consumer goods. Well-known holdings include Nestlé and Novartis. The fund uses a rules-based approach that looks at things like company quality and price trends, aiming for long-term growth and broad global diversification beyond the U.S. A key risk is that foreign stocks can be volatile and their prices can go up and down with global markets and currency swings.
How much will it cost me?
This ETF has an expense ratio of 0.39%, which means you’ll pay about $3.90 per year for every $1,000 you invest. That’s a bit higher than the average index ETF because it uses a more complex, actively managed multi-factor strategy rather than a simple passive index approach.
What would affect this ETF?
MFDX could benefit if developed markets outside the U.S. grow steadily, especially in sectors like financials, industrials, and consumer companies, and if its multi-factor approach (including value and quality) helps it adapt well to changing market conditions. On the negative side, weaker global growth, rising interest rates that hurt banks and cyclical sectors, currency swings, or new regulations affecting major holdings such as European energy, materials, and financial firms could weigh on future returns.
MFDX Top 10 Holdings
MFDX leans heavily on a mix of European defensives and Asian tech, with a few standout names steering returns. Rising health care giants like Novartis and Roche are giving the fund a solid backbone, while BP’s steady climb in energy adds extra fuel. On the growth side, chip-related players Advantest and ASML have been strong longer-term drivers, even if their recent moves are a bit mixed. Meanwhile, financials such as Banco Santander and Zurich Insurance are lagging, slightly weighing on performance. Overall, it’s a diversified developed-markets ex-U.S. play with no single stock dominating the story.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 CH:NOVN | Novartis AG | 1.04% | $4.43M | CHF 243.61B | 30.57% | 80Outperform |
 CH:NESN | Nestlé SA | 0.94% | $4.00M | CHF 220.83B | 8.82% | 71Outperform |
 NL:ASML | ASML Holding NV | 0.83% | $3.55M | EUR 490.32B | 43.37% | 76Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 CH:ZURN | Zurich Insurance Group | 0.77% | $3.29M | CHF 92.74B | 11.50% | 78Outperform |
 GB:GLEN | Glencore | 0.76% | $3.25M | GBP 57.97B | 37.64% | 68Neutral |
 ES:SAN | Banco Santander | 0.76% | $3.22M | EUR 155.53B | 19.60% | 73Outperform |
 GB:BP | BP p.l.c. | 0.75% | $3.19M | GBP 86.45B | 21.95% | 71Outperform |
 ES:IBE | Iberdrola | 0.73% | $3.09M | EUR 149.37B | 27.46% | 67Neutral |
 GB:SHEL | Shell (UK) | 0.66% | $2.83M | GBP 211.09B | 30.61% | 73Outperform |
MFDX Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MFDX, the sentiment is Negative. The current price of 39.87 is below the 20-day moving average (MA) of 41.04, below the 50-day MA of 41.54, and below the 200-day MA of 41.05, indicating a bearish trend. The MACD of -0.26 indicates Positive momentum. The RSI at 35.55 is Neutral, neither overbought nor oversold. The STOCH value of 33.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MFDX.
MFDX Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| MFDX | $39.87 | $43.00(7.86% Upside) | $411.47M | 0.39% | 64Neutral |
 FYLD | $38.76 | $42.81(10.45% Upside) | $760.46M | 0.59% | 62Neutral |
 TLTD | $98.41 | $114.25(16.10% Upside) | $668.64M | 0.39% | 65Neutral |
 TXUE | $34.71 | $39.44(13.64% Upside) | $597.07M | 0.65% | 65Neutral |
 AVSD | $78.18 | $89.34(14.28% Upside) | $374.48M | 0.23% | 65Neutral |
 IDLV | $35.83 | $38.27(6.80% Upside) | $348.31M | 0.25% | 61Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MFDX | PIMCO RAFI Dynamic Multi-Factor International Equity ETF | 39.87 | 2.95 | 7.98% | |
| FYLD | Cambria Foreign Shareholder Yield ETF | 38.76 | 7.68 | 24.70% | |
| TLTD | FlexShares Morningstar Developed Markets ex-US Factor Tilt | 98.41 | 10.58 | 12.04% | |
| TXUE | Thornburg International Equity ETF | 34.71 | 3.87 | 12.56% | |
| AVSD | Avantis Responsible International Equity ETF | 78.18 | 6.97 | 9.79% | |
| IDLV | Invesco S&P International Developed Low Volatility ETF | 35.83 | 3.52 | 10.89% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.